Martin Price

Views & Analysis

The world of life sciences is changing rapidly, and the traditional ways of assessing drugs may no longer be fit for purpose.

Oncology

Luke Piggot, a principal scientist at Debiopharm, shares some recent data and news about the company's work in DNA damage repair inhibitors.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.